rs17225943
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_000135.4(FANCA):āc.755A>Gā(p.Asp252Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00317 in 1,614,182 control chromosomes in the GnomAD database, including 163 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_000135.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FANCA | NM_000135.4 | c.755A>G | p.Asp252Gly | missense_variant | 8/43 | ENST00000389301.8 | NP_000126.2 | |
FANCA | NM_001286167.3 | c.755A>G | p.Asp252Gly | missense_variant | 8/43 | NP_001273096.1 | ||
FANCA | NM_001018112.3 | c.755A>G | p.Asp252Gly | missense_variant | 8/11 | NP_001018122.1 | ||
FANCA | NM_001351830.2 | c.659A>G | p.Asp220Gly | missense_variant | 7/10 | NP_001338759.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FANCA | ENST00000389301.8 | c.755A>G | p.Asp252Gly | missense_variant | 8/43 | 1 | NM_000135.4 | ENSP00000373952.3 |
Frequencies
GnomAD3 genomes AF: 0.0170 AC: 2592AN: 152200Hom.: 83 Cov.: 32
GnomAD3 exomes AF: 0.00452 AC: 1137AN: 251424Hom.: 26 AF XY: 0.00323 AC XY: 439AN XY: 135910
GnomAD4 exome AF: 0.00173 AC: 2527AN: 1461864Hom.: 80 Cov.: 32 AF XY: 0.00147 AC XY: 1072AN XY: 727234
GnomAD4 genome AF: 0.0170 AC: 2591AN: 152318Hom.: 83 Cov.: 32 AF XY: 0.0164 AC XY: 1222AN XY: 74486
ClinVar
Submissions by phenotype
Fanconi anemia complementation group A Benign:3
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 28, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Benign, criteria provided, single submitter | clinical testing | KCCC/NGS Laboratory, Kuwait Cancer Control Center | Jul 07, 2023 | - - |
not specified Benign:2Other:1
not provided, no classification provided | reference population | ITMI | Sep 19, 2013 | - - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, criteria provided, single submitter | clinical testing | Quest Diagnostics Nichols Institute San Juan Capistrano | Mar 30, 2021 | - - |
not provided Benign:2
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 25, 2019 | - - |
Fanconi anemia Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at